Mohammad Ebadul Karim MP, Managing Director of Beacon Pharmaceuticals, a top oncology drug maker in Bangladesh has been honored with the prestigious Fellowship in Minimal Access Surgery (F.MAS) award.
The award was conferred to Mr. Karim, also a member of the parliament of Bangladesh, during the 17th Annual International Conference of the Association of Minimal Access Surgeons of India (AMASICON 2022) for his outstanding contribution to the sector.
The Association of Minimal Access Surgeons of India (AMASI) organized the event at Kiranshree Grand Hotel in Guwahati, the northeast Indian state of Assam on November 18, 2022.
All members of the Beacon family are highly delighted with the award and felt proud of this glorious achievement. The outstanding contribution to the medical field in Bangladesh will help take the sector forward.
The Beacon family also believes that their expectation to ensure a better healthcare system for the people in home and abroad will be fulfilled and the recognition will be remembered as the key to success in the future.
Beacon Pharmaceuticals is the number one oncology company and one of the leading and fastest-growing pharmaceutical companies in Bangladesh.
The Company started its journey in 2006 and it emerges as the top oncology pharmaceutical company in Bangladesh.
